Brief: Arecor Therapeutics Says Hikma Communicated Its Intention To Continue Development Of At307
07/09/2023 07:46
Sept 7 (Reuters) - Arecor Therapeutics PLC AREC.L :
* POSITIVE HIKMA FDA PRE-IND MEETING
* HIKMA COMMUNICATED TO ARECOR ITS INTENTION TO CONTINUE
DEVELOPMENT OF AT307 IN US USING FDA'S505(B)(2) REGULATORY
PATHWAY
Source text for Eikon: ID:nRSG6326La
Further company coverage: AREC.L
((Reuters.Briefs@thomsonreuters.com;;))